Biomerica (NASDAQ:BMRA) Announces Quarterly Earnings Results

Biomerica (NASDAQ:BMRA) announced its quarterly earnings data on Monday. The company reported ($0.06) EPS for the quarter, Zacks reports. Biomerica had a negative net margin of 100.52% and a negative return on equity of 90.19%. The firm had revenue of $1.12 million for the quarter.

Biomerica Price Performance

Shares of BMRA opened at $0.57 on Wednesday. The firm has a market cap of $10.45 million, a P/E ratio of -1.68 and a beta of 0.37. The company has a 50 day simple moving average of $0.66 and a two-hundred day simple moving average of $0.47. Biomerica has a 1 year low of $0.24 and a 1 year high of $1.27.

About Biomerica

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.